181
Views
0
CrossRef citations to date
0
Altmetric
Clinical Research

A randomized controlled trial and prospective cohort investigating antivenom for red-bellied black snake envenomation

ORCID Icon, , ORCID Icon, & ORCID Icon
Received 14 Mar 2024, Accepted 07 Jun 2024, Published online: 24 Jun 2024

References

  • Kasturiratne A, Wickremasinghe AR, de Silva N, et al. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med. 2008;5(11):e218. doi:10.1371/journal.pmed.0050218.
  • Johnston CI, Ryan NM, Page CB, et al. The australian snakebite project, 2005-2015 (ASP-20). Med J Aust. 2017;207(3):119–125.
  • Isbister GK, Scorgie FE, O'Leary MA, et al. Factor deficiencies in venom-induced consumption coagulopathy resulting from Australian elapid envenomation: australian Snakebite Project (ASP-10). J Thromb Haemost. 2010;8(11):2504–2513.
  • Johnston CI, Isbister GK. Australian snakebite myotoxicity (ASP-23). Clin Toxicol (Phila). 2021;59(7):611–618. doi:10.1080/15563650.2020.1836377.
  • Noutsos T, Currie BJ, Isoardi KZ, et al. Snakebite-associated thrombotic microangiopathy: an Australian prospective cohort study [ASP30]. Clin Toxicol (Phila). 2022;60(2):205–213. doi:10.1080/15563650.2021.1948559.
  • Campbell CH. Myotoxic paralysis and hemolytic anemia due to king brown snake bite. Aust N Z J Med. 1984;14(2):169.
  • Maduwage K, Buckley NA, de Silva HJ, et al. Snake antivenom for snake venom induced consumption coagulopathy. Cochrane Database Syst Rev. 2015;2015(6):CD011428.
  • Silva A, Hodgson WC, Isbister GK. Antivenom for Neuromuscular Paralysis Resulting From Snake Envenoming. Toxins (Basel). 2017;9(4):143. doi:10.3390/toxins9040143.
  • Johnston CI, Brown SG, O'Leary MA, et al. Mulga snake (Pseudechis australis) envenoming: a spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy - Australian Snakebite Project (ASP-19). Clin Toxicol (Phila). 2013;51(5):417–424. doi:10.3109/15563650.2013.787535.
  • Churchman A, O'Leary MA, Buckley NA, et al. Clinical effects of red-bellied black snake (Pseudechis porphyriacus) envenoming and correlation with venom concentrations: australian Snakebite Project (ASP-11). Med J Aust. 2010;193(11-12):696–700.
  • Lalloo DG, Trevett AJ, Korinhona A, et al. Snake bites by the Papuan taipan (Oxyuranus scutellatus canni): paralysis, hemostatic and electrocardiographic abnormalities, and effects of antivenom. Am J Trop Med Hyg. 1995;52(6):525–531. doi:10.4269/ajtmh.1995.52.525.
  • Mion G, Larréché S, Benois A, et al. Hemostasis dynamics during coagulopathy resulting from Echis envenomation. Toxicon. 2013;76:103–109. doi:10.1016/j.toxicon.2013.09.003.
  • Silva A, Scorgie FE, Lincz LF, et al. Indian Polyvalent Antivenom Accelerates Recovery From Venom-Induced Consumption Coagulopathy (VICC) in Sri Lankan Russell’s Viper (Daboia russelii) Envenoming. Front Med (Lausanne). 2022;9:852651. doi:10.3389/fmed.2022.852651.
  • Isbister GK, Duffull SB, Brown SG. Failure of antivenom to improve recovery in Australian snakebite coagulopathy. QJM. 2009;102(8):563–568. doi:10.1093/qjmed/hcp081.
  • Pearn J, McGuire B, McGuire L, et al. The envenomation syndrome caused by the Australian Red-bellied Black Snake Pseudechis porphyriacus. Toxicon. 2000;38(12):1715–1729. doi:10.1016/s0041-0101(00)00102-1.
  • AMH. Tiger snake antivenom: in Australian Medicines Handbook (online). Adelaide: Australian Medicines Handbook Pty Ltd.; 2024. https://amhonline.amh.net.au/
  • Isbister GK, Buckley NA, Page CB, et al. A randomized controlled trial of fresh frozen plasma for treating venom-induced consumption coagulopathy in cases of Australian snakebite (ASP-18). J Thromb Haemost. 2013;11(7):1310–1318.
  • O'Leary MA, Isbister GK, Schneider JJ, et al. Enzyme immunoassays in brown snake (Pseudonaja spp.) envenoming: detecting venom, antivenom and venom-antivenom complexes. Toxicon. 2006;48(1):4–11. doi:10.1016/j.toxicon.2006.04.001.
  • Allen GE, Brown SG, Buckley NA, et al. Clinical effects and antivenom dosing in brown snake (Pseudonaja spp.) envenoming–Australian snakebite project (ASP-14). PLoS One. 2012;7(12):e53188. doi:10.1371/journal.pone.0053188.
  • Isbister GK, Buckley NA, Brown SG. Tiger snake (Notechis spp) envenoming: australian Snakebite Project (ASP-13). Med J Aust. 2013;198(4):194–195. doi:10.5694/mja12.11690.
  • Sanhajariya S, Duffull SB, Isbister GK. Investigating myotoxicity following Australian red-bellied black snake (Pseudechis porphyriacus) envenomation. PLoS One. 2021;16(9):e0256653. doi:10.1371/journal.pone.0256653.
  • Gulati A, Isbister GK, Duffull SB. Effect of Australian elapid venoms on blood coagulation: australian Snakebite Project (ASP-17). Toxicon. 2013;61:94–104. doi:10.1016/j.toxicon.2012.11.001.
  • Isbister GK, Brown SG, Page CB, et al. Snakebite in Australia: a practical approach to diagnosis and treatment. Med J Aust. 2013;199(11):763–768.
  • Isbister GK, White J, Currie BJ, et al. Clinical effects and treatment of envenoming by Hoplocephalus spp. snakes in Australia: australian Snakebite Project (ASP-12). Toxicon. 2011;58(8):634–640. doi:10.1016/j.toxicon.2011.09.013.
  • Kulawickrama S, O'Leary MA, Hodgson WC, et al. Development of a sensitive enzyme immunoassay for measuring taipan venom in serum. Toxicon. 2010;55(8):1510–1518. doi:10.1016/j.toxicon.2010.03.003.
  • Ryan NM, Kearney RT, Brown SG, et al. Incidence of serum sickness after the administration of Australian snake antivenom (ASP-22). Clin Toxicol (Phila). 2016;54(1):27–33. doi:10.3109/15563650.2015.1101771.
  • Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol. 2004;114(2):371–376. doi:10.1016/j.jaci.2004.04.029.
  • Sampson HA, Muñoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report–Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117(2):391–397. doi:10.1016/j.jaci.2005.12.1303.
  • Lim AY, Singh PN, Isbister GK. Severe rhabdomyolysis from red-bellied black snake (Pseudechis porphyriacus) envenoming despite antivenom. Toxicon. 2016;117:46–48. doi:10.1016/j.toxicon.2016.03.016.
  • Johnston CI, Ryan NM, O'Leary MA, et al. Australian taipan (Oxyuranus spp.) envenoming: clinical effects and potential benefits of early antivenom therapy - Australian Snakebite Project (ASP-25). Clin Toxicol (Phila). 2017;55(2):115–122. doi:10.1080/15563650.2016.1250903.
  • Isbister GK, Brown SG, Investigators ASP. Bites in Australian snake handlers–Australian snakebite project (ASP-15). QJM. 2012;105(11):1089–1095. doi:10.1093/qjmed/hcs132.
  • Isbister GK, Tankel AS, White J, et al. High rate of immediate systemic hypersensitivity reactions to tiger snake antivenom. Med J Aust. 2006;184(8):419–420. doi:10.5694/j.1326-5377.2006.tb00297.x.
  • TherapeuticGuidelines. Toxicology and toxinology. Melbourne: Therapeutic Guidelines Ltd.; 2020.
  • Lincz LF, Scorgie FE, Johnston CI, et al. Comparative sensitivity of commercially available aPTT reagents to mulga snake (Pseudechis australis) venom. Pathology. 2014;46(5):444–449. doi:10.1097/PAT.0000000000000120.